Rollin, Michael

Rollin, Michael was paid $7.48M by Medicaid between Sep 2021 and Feb 2024, across 8 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 80% of everything it billed.

Compared with peers

Next to other Nurse Practitioner providers in New York

Rank by total paid#1 of 346

Median peer was paid$1K

This provider vs. median5,214×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2021	10,307	$323K
2022	239,485	$4.24M
2023	137,199	$2.91M
2024incomplete	31	$1K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	80%	128,799	43,057	$5.97M
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	20%	128,788	43,049	$1.50M
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	<1%	283	268	$4K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	125,566	40,318	$2K
87811	Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19)	<1%	20	19	$579.32
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	3,528	2,957	$261.38
99202	Office or other outpatient visit for the evaluation and management of a new patient, straightforward	<1%	26	26	$33.07
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	12	12	$3.75

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.